NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year revenue growth rate
3Y CAGR
-56.4%/yr
Quarterly compound
Percentile
P67
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.53% |
| Q3 2025 | 61.61% |
| Q2 2025 | 22.32% |
| Q1 2025 | -57.65% |
| Q4 2024 | 1102.48% |
| Q3 2024 | -67.03% |
| Q2 2024 | -40.04% |
| Q1 2024 | 40.88% |
| Q4 2023 | 31.80% |
| Q3 2023 | 17.76% |
| Q2 2023 | 35.12% |
| Q1 2023 | 306.86% |
| Q4 2022 | 66.57% |
| Q3 2022 | 114.63% |
| Q2 2022 | -12.40% |
| Q1 2022 | 8.40% |
| Q4 2021 | -30.18% |
| Q3 2021 | 20.55% |
| Q2 2021 | 119.82% |
| Q1 2021 | -74.48% |
| Q4 2020 | -96.29% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | -63.70% |